ATOVAQUONE/PROGUANIL BGR 250 mg/100 mg, film-coated tablet 12 tablets
Active ingredients: Atovaquone, Proguanil hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet12 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ATOVAQUONE/PROGUANIL BGR 250 mg/100 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 12 comprimé(s)
- Marketing authorisation holder
- BIOGARAN
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Prévention du paludisme pour certains assurés sociaux de Guyane ; JOURNAL OFFICIEL ; 14/02/07
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 30 Oct 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66395950CIP74966886CIP133400949668861Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ATOVAQUONEcomprimé | 250,00 mg · un comprimé | SA |
| CHLORHYDRATE DE PROGUANILcomprimé | 100,00 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.